Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction

Clinical Cardiology

Volumn 28, Issue 3, 2005, Pages 149-153

  Blum, Arnon ^a,b   Hadas, Vered ^a   Burke, Michael ^a   Yust, Israel ^a   Kessler, Ada ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Poriya Hospital   (Israel)

Author keywords

Atherosclerosis; Endothelial dysfunction; Human immunodeficiency virus; Viral load

Indexed keywords

AMPRENAVIR; CD4 ANTIGEN; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; HYPERTRIGLYCERIDEMIA; LYMPHOCYTE COUNT; PATHOGENESIS; RISK FACTOR; VIRUS LOAD;

EID: 14944344774     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280311     Document Type: Article

References (22)

1. Passalaris JD, Sepkowitz KA, Glesby MJ: Coronary artery human immunodeficiency virus infection. Clin Infect Dis 2000;31(3):787-797
2. Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA: Endothelial cell dysfunction in HIV infection. J Acq Immune Defic Syndr 1992;5(2):127-131
3. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE: Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265(5170):391-394
4. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H: High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 1998;81(7):866-888
5. Shah F: Link between infection and atherosclerosis: Who are the culprits: Viruses, bacteria, both, or neither? Circulation 2001;103(1):5-6
6. Celermajer DS, Sorensen KE, Gooch VM: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115
7. Behrens G, Schmidt H, Meyer D, Stoll M, Schmidt RE: Vascular complications associated with use of HIV protease inhibitors (comment). Lancet 1998;351:1958
8. Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen JD, Daley J: Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328
9. Stein JH, Klein MA, Bellehumeur JL, Aeschlimann SE, McBride PE, Sosman JM: Use of human immunodeficiency virus-1 protease inhibitors is associated with endothelial dysfunction (letter). American Heart Association 2000;II-7:3812
10. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, Gastaut JA: Endothelial cell dysfunction in HIV infection. J Acq Immune Defic Syndr 1991;5(2): 127-131
11. Fabricant CG, Fabricant J, Litrenta MM, Minick CR: Virus induced atherosclerosis. J Exp Med 1978;148:335-340
12. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME: Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;2(8351):644-647
13. Hendrix MGR, Salimans MMM, van Boven CRA, Bruggeman CA: High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-28
14. Adam E, Melnick JL, Probtsfield JL, Petrie BL, Burek J, Bailey KR, McCollum CH, DeBakey ME: High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2: 291-293
15. Zhou YF, Leon MB, Waclawin MA, Popma JJ, Yu ZX, Finkel T, Epstein SE: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-630
16. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M: Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-927
17. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M: A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary artery disease: The atherosclerosis Risk In Communities (ARIC) study. Arch Intern Med 2000;160(13):2027-2032
18. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE: The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000;182(6):1583-1587
19. Lin TM, Jiang MJ, Eng HL, Shi GY, Lai LC, Huang BJ, Huang KY, Wu HL: Experimental infection with bovine herpesvirus-4 enhances atherosclerotic process in rabbits. Lab Invest 2000;80(1):3-11
20. Zhu J, Nieto J, Horne BD, Anderson JL, Muhlestein JB, Epstein SE: Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001;103:45-57
21. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA: Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation 2002;106:184-197
22. Tabib A, Leroux C, Mornex JF, Loire R: Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus- positive patients. Coron Artery Dis 2000;11(1):41-46